Credit: Danaher Corporation ( DHR ) on Monday said it would buy fellow medical instruments maker Beckman Coulter, Inc. ( BEC ) for $6.8 billion in cash.
The $83.50 per-share acquisition price represents an 11% premium over BEC's Friday closing price of $75.17.
The deal is expected to close in the first half of this year. The buyout is structured as a tender offer where Danaher will buy all outstanding Beckman shares. Following that process, the two companies will merge.
Danaher shares rose $2.52, or +5.3%, in premarket trading Monday.
The Bottom Line
Shares of Danaher ( DHR ) have a .17% dividend yield, based on Friday's closing stock price of $47.98. The stock has technical support in the $44 price area. The share are trading near all-time highs and have little overhead resistance.
Danaher Corporation ( DHR ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.
Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Created by Dividend.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
